Buy or sell Proprio Vision stock pre IPO via an EquityZen fund
Proprio Vision Stock
Proprio uses machine learning, computer vision, and augmented reality user interfaces to improve the accuracy and efficiency of surgery
About Proprio Vision Stock
Proprio is a Seattle-based company utilizing machine learning, automated intelligence, and mixed-reality user interfaces to develop a next generation surgical navigation and imaging platform to improve surgical accuracy, simplify surgical workflows, and improve patient outcomes. The solution we’re building supplants surgical microscopes, navigation systems, loupes, and screens, etc. Replacing surgical microscopes alone wouldn’t be a compelling enough goal for us though. Our greater vision is to move medicine out of the past and into a future that fully leverages not only existing technologies, like AR/VR, but one where medical innovation can move at the pace of software development in other industries. In order to realize that future, we have to move away from a dependency on ground glass, in the case of microscopes, and toward a focus on software and data, and leverage the emerging capabilities of computer vision and machine learning to enhance the combined performance of humans and computers. That’s our mission.